Biotechnology Veteran David Hung, M.D. Launches Stealth Start-Up Focusing on the Foremost Unmet Needs in Oncology
Nuvation Bio's Proprietary Portfolio Includes Seven Novel and Mechanistically Distinct Oncology Programs, Each with Multiple Drug Development Candidates
NEW YORK, Oct. 28, 2019 /PRNewswire/ -- N...
Collaboration will combine Lyell’s technologies with GSK’s pipeline of cell therapies and manufacturing capability
Issued: London and San Francisco
GlaxoSmithKline plc today announced a five-year collaboration with Lyell Immunopharma, a San Francisco biotechnology company, to develop new technologies to imp...